Nath Bio-Genes (India) Ltd

(NATHBIOGEN)

Nath BioGenes India Limited was established in 1993, as a private limited company, to produce, process and market hybrid and GM seeds. With 16 business centers spanning 131 territories across India, it has an extensive network of 2000 distributors, enabling it to cater to PAN India and far abroad markets in Asia, Africa and the Middle East. To improve the quality of its production, the company has incorporated modern infrastructure facilities, biotech and seed technology labs. Their range of field crop, vegetable crop and plant nutrient supplements have enabled it to gain various prestigious awards, such as the Vasantrao Naik Prathisthan Award, for its contribution towards enhancing agricultural productivity. It has also collaborated with major International and National Centres of Excellence, such as the NRCPB, CIMMYT, IRRI, and ICRISAT. The company has set rigorous field standards, quality control checks, and elaborate seed processing facilities, to ensure that only seeds of the highest quality reaches customers. Its 3-phase trial system with 40 testing locations, 8 centres, and all agroclimatic zones of India, has enabled it to rigorously test products and compare yields with competitor products. This comprehensive system has allowed Nath BioGenes India Limited to be a successful hybrid and GM seed provider in India and internationally.

Share Price: ₹172.35 per share as on 21 Nov, 2024 04:01 PM
Market Capitalisation: ₹334.17Cr as of today
Revenue: ₹32.19Cr as on September 2024 (Q3 24)
Net Profit: ₹1.11Cr as on September 2024 (Q3 24)
Listing date: 28 Jan, 2014